investorscraft@gmail.com

Intrinsic ValueManolete Partners Plc (MANO.L)

Previous Close£51.00
Intrinsic Value
Upside potential
Previous Close
£51.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2025 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Manolete Partners Plc is a specialized insolvency litigation financing firm operating exclusively in the UK market. The company acquires and funds insolvency-related legal claims, providing capital to insolvency practitioners in exchange for a share of recovered proceeds. This niche business model capitalizes on the UK’s robust insolvency framework, where litigation funding helps maximize asset recoveries for creditors. Manolete holds a unique position as one of the few publicly traded litigation funders focused solely on insolvency cases, differentiating itself from broader litigation finance peers. The firm’s expertise in assessing case merits and managing legal risks underpins its competitive edge. While the market remains fragmented, Manolete benefits from established relationships with insolvency practitioners and a track record of successful case resolutions. Regulatory tailwinds, including growing acceptance of litigation funding, further support its positioning in this specialized segment of the legal and financial services industry.

Revenue Profitability And Efficiency

Manolete reported revenue of £26.3 million for FY 2024, reflecting its core income from litigation recoveries. Net income stood at £0.9 million, indicating modest profitability amid operational challenges. The negative operating cash flow of £1.4 million suggests timing mismatches between case funding and recoveries, a common dynamic in litigation financing. Capital expenditures were negligible, consistent with the asset-light nature of the business.

Earnings Power And Capital Efficiency

The company’s diluted EPS of 2.07p underscores the capital-intensive and cyclical nature of insolvency litigation, where earnings are tied to case outcomes and realization timelines. Manolete’s ability to generate returns depends on its underwriting discipline and the UK’s insolvency activity levels, which can fluctuate with economic conditions.

Balance Sheet And Financial Health

Manolete’s balance sheet shows £1.5 million in cash against £13.7 million of total debt, indicating reliance on leverage to fund case acquisitions. The debt load warrants monitoring given the unpredictable timing of litigation proceeds. The absence of tangible assets highlights the working capital-intensive model, with liquidity tied to case resolutions.

Growth Trends And Dividend Policy

Growth is contingent on case volume and successful recoveries, both sensitive to macroeconomic trends. The company did not pay dividends in FY 2024, retaining capital for case funding. Historical performance suggests variability in earnings, reflecting the inherent lumpiness of litigation outcomes.

Valuation And Market Expectations

With a market cap of £36.8 million, the stock trades at a significant discount to revenue, likely reflecting investor caution around cash flow volatility and leverage. The beta of 0.7 indicates lower systemic risk than the broader market, though idiosyncratic case risks dominate.

Strategic Advantages And Outlook

Manolete’s deep expertise and first-mover advantage in UK insolvency litigation provide strategic differentiation. However, the outlook remains tied to judicial backlogs, economic distress levels, and regulatory shifts in litigation funding. Prudent case selection and balance sheet management will be critical to navigating cyclical headwinds.

Sources

Company filings, London Stock Exchange disclosures

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2026202720282029203020312032203320342035203620372038203920402041204220432044204520462047204820492050

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount